Melatonin is produced only during nighttime darkness. Its onset during
the evening is a useful marker for circadian phase position, when mel
atonin levels are sampled frequently and under conditions of dim light
or darkness. This marker is termed the dim light melatonin onset (DLM
O). Recently, we have described a phase response curve (PRC) to melato
nin in humans that is about 12 h out of phase with the PRC to light. E
xogenous melatonin administration and bright light exposure can be use
d to shift circadian rhythms according to their respective PRCs. These
phase-resetting agents can be used alone or together to treat circadi
an phase disorders, which include advanced and delayed sleep phase syn
drome, shift work maladaptation, jet lag and winter depression. Endoge
nous melatonin may function to augment entrainment of circadian rhythm
s by the light-dark cycle.